BIA: positive messages for life sciences

he UK BioIndustry Association’s (BIA) Bioscience Forum—Building the third global cluster, held in London on October 15, provided a 300-strong audience with a positive message about the biotechnology industry in the UK.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotech

Regeneron and Amgen call a truce on two Eylea biosimilar patents

28 October 2026 Both companies have agreed to dismiss claims and counterclaims involving Amgen’s 2 mg aflibercept biosimilar, while their wider feud continues.

Biotech

10x and Parse set to end sequencing feud after appeals court defeat

23 October 2026 Following the Federal Circuit’s decision to uphold the invalidation of three patents, the parties are set to drop their remaining claims, despite 10x’s separate multi-million dollar jury win.

Biotech

Guardant loses second patent challenge to TwinStrand amid $245m damages fallout

16 October 2026 All 30 claims of a key DNA sequencing patent have been upheld for a second time, marking another setback in a long-running dispute that has already left Guardant facing a $245 million bill.

More features

Latham lands pharma and tech expert in London

Regeneron and Amgen call a truce on two Eylea biosimilar patents

Mewburn Ellis hires first CTO to boost investment in AI and digital innovation

10x and Parse set to end sequencing feud after appeals court defeat

Dr Reddy’s eyes appeal stakes as Boehringer hearing ends

Boehringer accuses Dr Reddy’s of ‘weaponising’ plausibility

Guardant loses second patent challenge to TwinStrand amid $245m damages fallout

Boehringer and Dr Reddy’s spar over plausibility as trial wraps up

BIA: positive messages for life sciences

More on this story

Editor's picks

Editor's picks

More features